跳至主要内容
临床试验/NCT02308839
NCT02308839已完成不适用

Study of the GORE® EXCLUDER® Endoprosthesis in the Treatment of Infra-renal Abdominal Aortic Aneurysms

W.L.Gore & Associates1 个研究点 分布在 1 个国家目标入组 181 人开始时间: 2012年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
181
试验地点
1
主要终点
Percentage of Participants Survived at 5 Years

研究概览

简要总结

This is a French Registry mandated by the French National Health Authority assessing long-term (5-years) safety of the GORE® Excluder® Endoprosthesis in the treatment of infra-renal Abdominal Aortic Aneurysms (AAA).

详细描述

The use of abdominal aortic endoprostheses makes the treatment of infra-renal abdominal aortic aneurysms possible, with implantation via the femoral artery, thus avoiding a very invasive surgical procedure. The French National Authority for Health requires a 5-year follow-up as part of the renewal for reimbursement for these endoprostheses.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Any patients requiring abdominal aortic stenting for the treatment of an unruptured infra-renal aortic abdominal aneurysm.

排除标准

  • Patients whose clinical follow-up is not possible, i.eg, patient who cannot return for control visits (e.g. patients living abroad).

结局指标

主要结局

Percentage of Participants Survived at 5 Years

时间窗: 5 years

Kaplan-Meier estimate of participant survival at 5 years

次要结局

  • Percentage of Participants Free From Aneurysm Diameter Growth at 5 Years(5 years)
  • Percentage of Participants Free From Surgical Conversion at Procedure(Index Procedure)
  • Percentage of Participants Free From Migration at 5 Years(5 years)
  • Percentage of Participants Free From Endoleak at 5 Years(5 years)
  • Percentage of Participants Free From Aneurysm Related Mortality at 5 Years(5 years)
  • Percentage of Participants Free From Endovascular or Surgical Re-intervention at 5 Years(5 years)

研究者

发起方
W.L.Gore & Associates
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验